fbpx Skip to main content
 

Search

Discovery, Product Development & Supply

Discovery, Product Development & Supply
Discovery, Product Development & Supply
Multiple immunofluorescent imaging of tonsil immune cells from toxicology study evaluating NIK inhibitor for the treatment of Lupus. Kelsie Marks, Molecular Pathology, Preclinical Sciences & Translational Safety

Discovery, Product Development & Supply (DPDS) is the molecular invention, development, and delivery engine within Janssen. Our team targets the hardest-to-treat diseases, combining the expertise of our multi-disciplinary scientists with external innovators to unlock the most promising science and turn complex therapeutic concepts into transformational therapies for patients.

 

 

Driven to Deliver

Our global team of approximately 4,000 drug hunters, drug developers, and clinical supply experts are critical to reimagining the entire R&D process from inception to delivery of medicines to patients. Driven by innate curiosity, they translate the best ideas into differentiated therapies and innovative manufacturing capabilities to have a profound impact on human health.

“With our cross-functional approach to innovation, deep expertise, and global footprint, we aim to invent and develop transformational therapies for patients by exploring new pathways and embracing a source-agnostic, multi-modality treatment approach.”

Richard (Rich) Tillyer, Ph.D., Global Head, Discovery, Product Development & Supply

Mastering Discovery and Development

We are modality-agnostic, seeking to understand diseases at a molecular level and intervene most effectively in their biological pathways using small molecule and protein modalities, cell and gene therapies, and RNA therapeutics. Our lead-generation engine is comprised of powerful screening platforms and unique artificial intelligence tools that help us identify targets faster and more efficiently than ever before. We collaborate with world-class scientific innovators to create novel products that neither organization could achieve alone.

Unlocking Potential

We are fostering an inclusive scientific community, reducing barriers to STEM education, and investing in the next generation of scientific leaders. As part of our strong belief in the importance of diversity and inclusion in science, DPDS champions several initiatives within Johnson & Johnson, including the global R&D Postdoc & Ph.D. Fellowship Program and the Scientist Mentoring and Diversity Program (SMDP). Through these programs, DPDS has facilitated professional development and mentorship opportunities to enable a successful start to scientists’ careers.

In line with our commitment to fostering early career talent, DPDS has led engagements and development initiatives for Postdoc & Ph.D. students across Janssen. Within SMDP, scholars are paired with biotech industry mentors to increase the participation of underrepresented scientists in the pharmaceutical industry. Johnson & Johnson holds an annual Open House event, during which graduate students and postdoctoral fellows network with R&D scientists and showcase their research through a poster session.

Additionally, DPDS employees participate in the Women in Science, Technology, Engineering, Math, Manufacturing, and Design initiative to support women pursuing their STEM2D degrees throughout regions surrounding our campuses.

Through an ongoing partnership with Rutgers University, now in its third year, DPDS has hosted 40 diverse clinical scientist trainees to tour our labs, explore career opportunities, and meet with leaders across the organization.

In collaboration with the University of Pennsylvania’s Penn LENS (Laboratory Experiences in Natural Sciences) program, we hosted young scientists from underserved communities to visit our discovery labs, explore potential career paths, and set them on a trajectory for successful careers in science.